Initiative will provide services to assess the mechanical and physical properties of materials, and the biological properties of material-tissue interfaces.
The non-invasive, multi-region intestinal sampling device sheds light on gut activities that were previously unmeasurable via endoscopy and stool samples.
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm to identify and triage patients suspected of suffering from HCM.